Live Markets »News & Advice»Market News»Market News Details
Market News Details

Natco Pharma Q3 net down 26% to Rs 159 cr on flat revenue, fall in margins

BS Reporter/Hyderabad 12 Feb 19 | 07:03 PM

Photo: Shutterstock

Hyderabad-based Natco Pharma Limited has reported a 26.72 per cent decline in consolidated net profit to Rs 159.3 crore for the quarter ended December 2018, owing to flattish revenues and fall in margins. 

Related Stories

    No Related Stories Found
Widgets Magazine

The company's consolidated revenues grew by little over one per cent to Rs 580 crore for the quarter under review, as compared to Rs 573.6 crore for the same quarter in the previous financial year and marginally lower on a sequential basis. However, the total expenditure rose 26 per cent to Rs 375.3 crore, from Rs 297.2 crore in the year-ago period.

ALSO READ: Natco Pharma to enter agrochemicals, set up Rs 100 crore facility in AP

The company attributed the decline in profits during the quarter predominantly to margin reduction of Oseltamivir in the US market. Formulations exports, including profit share, contributed Rs 257 crore to the total revenues, according to the company. The board of directors recommended an interim dividend of Rs 3.50 per equity share of Rs 2 each.

ALSO READ: Natco Pharma shifts focus from US, to spend 70% funds in emerging markets 

Widgets Magazine


Company Price Gain (%)
Bharti Airtel349.650.84
Power Grid Corpn194.650.23


Currently No Poll Available.

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine